PROFERO

Serial Number 88000887
606

Registration Progress

Application Filed
Jun 14, 2018
Under Examination
Jul 9, 2019
Approved for Publication
May 14, 2019
Published for Opposition
May 14, 2019
Registered

Trademark Image

PROFERO

Basic Information

Serial Number
88000887
Filing Date
June 14, 2018
Published for Opposition
May 14, 2019
Abandonment Date
August 15, 2022
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Aug 15, 2022
Classes
001 005 042 044

Rights Holder

The Translational Genomics Research Institute

03
Address
Suite 600
445 North Fifth Street
Phoenix, AZ 85004

Ownership History

The Translational Genomics Research Institute

Original Applicant
03
Phoenix, AZ

The Translational Genomics Research Institute

Owner at Publication
03
Phoenix, AZ

Legal Representation

Attorney
Bradley P. Hartman

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

38 events
Date Code Type Description Documents
Aug 15, 2022 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Aug 15, 2022 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jan 13, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 12, 2022 EX5G S SOU EXTENSION 5 GRANTED Loading...
Jan 12, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jan 5, 2022 EXT5 S SOU EXTENSION 5 FILED Loading...
Jan 5, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 6, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 2, 2021 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jul 2, 2021 EXT4 S SOU EXTENSION 4 FILED Loading...
Jul 2, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 24, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 22, 2020 EX3G S SOU EXTENSION 3 GRANTED Loading...
Dec 22, 2020 EXT3 S SOU EXTENSION 3 FILED Loading...
Dec 22, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 3, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 1, 2020 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jul 1, 2020 EXT2 S SOU EXTENSION 2 FILED Loading...
Jul 1, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 18, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 16, 2019 EX1G S SOU EXTENSION 1 GRANTED Loading...
Dec 16, 2019 EXT1 S SOU EXTENSION 1 FILED Loading...
Dec 16, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 9, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 14, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 14, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 24, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 1, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 13, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 13, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 11, 2019 ALIE A ASSIGNED TO LIE Loading...
Mar 8, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 10, 2018 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 10, 2018 GNRT F NON-FINAL ACTION E-MAILED Loading...
Sep 10, 2018 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 4, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 20, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 18, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
Chemical test kits for genetic testing for laboratory or research use; Assays and reagents for use in genetic research; Diagnostic preparations for scientific or research use; Nucleic acid isolation and purification kit consisting primarily of reagents for scientific research purposes; Reagents for scientific or medical research use; Clinical diagnostic preparations for clinical or medical laboratory use
Class 005
Testing kits comprised of medical diagnostic reagents and assays that test for the presence of certain genetic properties; Diagnostic agents, preparations and substances for medical purposes; Medical diagnostic reagents for the analysis of genetic material; Preparations for detecting changes in genes and gene expressions for medical purposes; Chemical reagents for medical analysis; Chemical preparation for use in medical analysis, particularly DNA analysis; Pharmaceutical preparations for diagnosis and for identifying and characterizing genetic abnormalities, tracking the progress of disease and measuring the effectiveness of therapies; Genetic identity tests comprises of reagents for medical purposes; Clinical diagnostic preparations for medical use
Class 042
Laboratory diagnostic services in the field of molecular science, comparative genome analysis, nucleic acid arrays and screening of nucleic acids; Medical and scientific research in the field of genetic testing and diagnosis and treatment of medical conditions; Development of tests and laboratory testing in the field of genetics and human disease; Scientific research consulting in the field of genetics, genomics, nucleic acid sequencing, and bioinformatics; Consulting services in the field of pharmaceutical research and development and laboratory testing; Genetic research, development and testing services; Genomic research, development and testing services for scientific research purposes; Nucleic acid collection, testing and analysis services for scientific research purposes; Genetic testing for scientific diagnostic research purposes; Genomic testing for scientific diagnostic research purposes; Medical and scientific research, development and consulting in the field of neurology; Medical and scientific research in the field of genetics and genetic engineering; Medical and scientific research and consulting in the fields of genomics and generation sequencing; Medical and scientific research in the field of disease treatment and diagnosis; Medical and scientific research relating to the design and development of treatment therapies; Data collection for research purposes, namely, the collection, testing and research of patient molecular and/or genomic data; Scientific clinical studies, namely, conducting clinical trials for others; Retrieval and correlation of genomic data for research or analysis purposes; Conducting clinical and pre-clinical trials; Targeted pharmaceutical drug development services; Genotyping services for research or analysis purposes; Gene screening for research or analysis purposes; Gene isolation and gene expression analysis for scientific and medical research purposes; Gene mapping; Gene analysis and biomarker discovery for scientific research and medical purposes; Research and development of identification and treatment methods for hereditary factors leading to disease; Nucleic acid-sequencing for scientific research purposes
Class 044
Medical diagnostic services in the field of molecular science, comparative genome analysis, nucleic acid arrays and screening of nucleic acids; Medical testing, analysis, and evaluation services for medical or diagnostic purposes for providing healthcare information; Providing health care information featuring information resulting from genomic research, testing, analysis, and evaluation; Diagnosis and treatment of medical conditions, namely, of cognitive, neurological, and brain-related conditions; Providing healthcare information; Providing information in the field of disease prevention, screening, diagnosis, and treatment for medical diagnostic and treatment purposes; Medical testing services for diagnostic or treatment purposes in the medical field; Proteogenomic profiling for diagnostic or treatment purposes of cognitive, neurological, and brain-related conditions; Identification of target molecules for disease treatment, namely, treatments of cognitive, neurological, and brain-related conditions

Additional Information

Translation
The English translation of "PROFERO" in the mark is "DELAY".

Classification

International Classes
001 005 042 044